Stock Events

Stock Events

Glenmark Pharmaceuticals (GLENMARK.NSE) Q4 2023 Earnings

14FebConfirmed

Q1 2023

Q2 2023

Q3 2023

Q4 2023

-12.46

-4.04

4.39

12.82

Details

Expected EPS

12.045902764896

Actual EPS

-12.464717265

Surprise EPS

-24.51

Surprise Percent

+203.48%

Description

Glenmark Pharmaceuticals (GLENMARK.NSE) has reported earnings of -12.464717265 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.